Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonheart-beating kidney donation: current practice and future developments.

Nicholas R Brook1, Julian R Waller, Michael L Nicholson

  • 1Division of Transplant Surgery, The Department of Surgery, University of Leicester, Leicester General Hospital, Leicester, United Kingdom. nicholasbrook@gfastmail.fm

Kidney International
|March 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

The Lancet. Oncology·2026
Same author

Transcriptomic profiling during normothermic machine perfusion of human kidneys reveals a pro-inflammatory cellular landscape and gene expression signature associated with severe ischemia-reperfusion injury and delayed graft function.

Frontiers in immunology·2025
Same author

Utilization and Transplantation of Unused Kidneys After Assessment Using Normothermic Machine Perfusion Technology.

Transplantation·2025
Same author

Subnormothermic acellular machine perfusion for prolonged preservation of human kidneys.

The British journal of surgery·2025
Same author

Protocol for a single-centre randomised pilot study to assess the safety and feasibility of adding a CytoSorb filter during kidney normothermic machine perfusion to remove inflammatory and immune mediators prior to kidney transplantation.

BMJ open·2025
Same author

IL-1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results.

Artificial organs·2024
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026
Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
See all related articles

Nonheart-beating kidney donation (NHBD) increases organ availability without higher costs. Despite initial function concerns, NHBD kidney transplants show long-term survival comparable to cadaveric donors, supporting its expanded use.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Organ donation strategies

Background:

  • Nonheart-beating kidney donation (NHBD) is an accepted method for expanding the donor pool.
  • Concerns exist regarding delayed graft function, acute rejection, and long-term survival in NHBD.
  • Ethical considerations and the need for tailored strategies for preservation and immunosuppression are critical.

Purpose of the Study:

  • To review current practices in NHBD kidney transplantation.
  • To examine and compare outcomes with cadaveric kidney donations.
  • To explore potential areas for development in NHBD kidney transplantation.

Main Methods:

  • A comprehensive literature review on NHBD kidney donation was conducted.

Related Experiment Videos

Main Results:

  • NHBD has increased kidney transplants by 16-40% with no evidence of higher costs.
  • Maastricht category 2 NHBDs are most common, with limited warm ischemia time (typically <40 minutes).
  • Machine perfusion shows superior initial function, reduced immunotherapy, and fewer dialysis sessions compared to static cold storage.

Conclusions:

  • NHBD kidneys demonstrate long-term allograft survival and equivalent serum creatinine levels to cadaveric kidneys, despite potentially poorer initial function.
  • Ongoing ethical reassessment is vital to increase donation ethically.
  • Viability assessment and tailored immunosuppression can further enhance NHBD kidney utilization.